Weight-loss drug boom in India: As patent lapses, generic Ozempic, Wegovy shots may cost Rs 3,000 Rs 4,000 per month Original makers Novo Nordisk not dropping price despite competition, says it is driven by patient trust, not patents With the patent of the blockbuster diabetes and weight loss drug semaglutide set to expire on March 20, nearly 50 generic brands are set to enter the market later this month
doi: 10.1016/S0140-6736(03)15268-3 [DOI] [PubMed] [Google Scholar] 7.Chinese Society of Health Management, Chinese Nutrition Society, Reproductive Medicine Branch of China International Exchange and Promotion Association for Medicine and Healthcare, China Health Promotion Foundation, Zhejiang Provincial Clinical Nutrition Center
Most municipalities and research institutions have sharps disposal programs that provide containers and pickup services
Reusing syringes introduces contamination risk that can invalidate results